A carregar...
Lysophosphatidic acid and its receptors LPA(1) and LPA(3) mediate paclitaxel-induced neuropathic pain in mice
BACKGROUND: Paclitaxel, which is widely used for the treatment of solid tumors, causes neuropathic pain via poorly understood mechanisms. Previously, we have demonstrated that lysophosphatidic acid (LPA) and its receptors (LPA(1) and LPA(3)) are required for the initiation of peripheral nerve injury...
Na minha lista:
| Publicado no: | Mol Pain |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4246549/ https://ncbi.nlm.nih.gov/pubmed/25411045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1744-8069-10-71 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|